Time for US companies to get to know the UPC

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Time for US companies to get to know the UPC

Managing IP is holding events in San Jose and New York in December to bring US companies up to date with everything they need to know about the Unified Patent Court and how it will affect them, with in-house counsel being offered complementary attendance

european-usa-forum.jpg

With the UPC completely reshaping the litigation landscape in Europe, now is the time for strategies to be put into place to prepare for this change. This is something that is uppermost in European companies’ priorities at the moment.

But are US companies falling behind in this regard?

They already have enough on their plates, with the fallout from recent Supreme Court decisions working their way through the courts and the USPTO, debates on patent trolls, and potential new legislation in Congress. As a result, US companies may not be focusing enough attention on the reform in Europe, giving away a strong competitive advantage to its European competitors.

A good place to start is with our handy overview of the biggest questions around the UPC and the Unitary Patent here and our guide to UPC resources here.

However, to really bring US corporations up to speed, Managing IP is holding the European Patent Reform Forum USA in San Jose on December 10 and New York on December 12. Registration is still open at www.managingip.com/eupatentusa

Join us to learn all you need to know about the UPC, get direct insights from the preparatory committee, hear from the EPO and listen to expert advice for US corporations to prepare for the reform.

As usual, attendance is free for in-house counsel, IP managers and R&D professionals. You can register at www.managingip.com/eupatentusa or simply email your details to register@managingip.com

The expert panels include leading European IP experts, a member of the drafting committee as well as well renowned US in-house counsel:

• Stefan Luninbuehl, international legal affairs, European Patent Office

• Pierre Véron, partner, Véron & Associés and member of the drafting committee

• Michael Schneider, partner, Wragge Lawrence Graham & Co

• Larry Horn, CEO, MPEG LA

• Catherine Lacavera, director of litigation, Google

• Pamela Simonton, executive vice president and general counsel, Exelixis Pharmaceuticals

• Sherry Knowles, principal, Knowles Intellectual Property Strategies

• Katy Motiey, Chief Legal Officer, Spansion

• Nicola Dagg, partner, Allen & Overy

• Michael Moore, deputy general counsel, Rambus

• Kim Jessum, associate general counsel, Heraeus Incorporated

• Roger Kuan, senior IP counsel, Thermo Fisher Scientific

• And many more

Register for free at: www.managingip.com/eupatentusa

or simply email your details to register@managingip.com

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article